Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


CNS Pharmaceuticals, Inc. (CNSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/16/2020 4 Keyes Jeffry R. (Director) has filed a Form 4 on CNS Pharmaceuticals, Inc.
Txns: Granted 46,559 options to buy @ $2.47, valued at $115k
06/16/2020 4 Gumulka Jerzy (Director) has filed a Form 4 on CNS Pharmaceuticals, Inc.
Txns: Granted 46,559 options to buy @ $2.47, valued at $115k
06/16/2020 4 Evans Carl Anthony (Director) has filed a Form 4 on CNS Pharmaceuticals, Inc.
Txns: Granted 46,559 options to buy @ $2.47, valued at $115k
06/16/2020 4 Andraczke Andrzej (Director) has filed a Form 4 on CNS Pharmaceuticals, Inc.
Txns: Granted 46,559 options to buy @ $2.47, valued at $115k
11/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/13/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
11/08/2019 3 Priebe Waldemar (10% Owner) has filed a Form 3 on CNS Pharmaceuticals, Inc.
11/08/2019 3 Keyes Jeffry R. (Director) has filed a Form 3 on CNS Pharmaceuticals, Inc.
11/08/2019 3 Gumulka Jerzy (Director) has filed a Form 3 on CNS Pharmaceuticals, Inc.
11/08/2019 3 Evans Carl Anthony (Director) has filed a Form 3 on CNS Pharmaceuticals, Inc.
11/08/2019 3 Climaco John M (CEO) has filed a Form 3 on CNS Pharmaceuticals, Inc.
11/08/2019 3 Andraczke Andrzej (Director) has filed a Form 3 on CNS Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy